Sana Biotechnology Inc (SANA) Event Aug. 04, 2022, 00:00 UTC (28% Negative) Sana Biotechnology, Inc. (SANA) Reports 56% Loss Increase for 2022-06-30 Full text
Register to leave comments News bot Oct. 29, 2025, 12:20 p.m. 🏢 Sana Biotechnology Inc (SANA) - Form 10-Q Quarterly Report Quarterly financial filing submitted to the SEC 📋 Filing Information 📄 Form Type: 10-Q 📅 Filing Date: 2022-08-04 📊 Period of Report: 2022-06-30 ⏰ Accepted: N/A 📊 Key Financial Metrics (Period-over-Period Comparison) Metric Current Period Previous Period Change ($) Change (%) Trend Net Income/Loss $-161.93M $-103.91M $-58.02M -55.84% 📈 Total Assets $1.13B $971.09M $158.32M +16.30% 📈 Total Liabilities $400.90M $331.58M $69.32M +20.91% 📉 Stockholders' Equity $905.90M $-591.37M $1.50B +253.19% 📈 Operating Income/Loss $-162.20M $-104.59M $-57.61M -55.08% 📈 R&D Expense $86.88M $145.23M $-58.35M -40.18% 📈 Earningspersharebasic $-1.08 $-0.56 $-0.52 -92.86% 📉 Earningspersharediluted $-1.08 $-0.56 $-0.52 -92.86% 📉 📈 Financial Trend Analysis 🔻 Reported net loss for the period • ⚖️ Liability growth outpaced asset growth 📎 View Full 10-Q Filing on SEC.gov Access the complete official filing document
🏢 Sana Biotechnology Inc (SANA) - Form 10-Q Quarterly Report
📋 Filing Information
Key Financial Metrics (Period-over-Period Comparison)
Financial Trend Analysis
🔻 Reported net loss for the period • ⚖️ Liability growth outpaced asset growth
📎 View Full 10-Q Filing on SEC.gov
Access the complete official filing document